In this Medical News Minute, developed exclusively for 

 of BMI and cortical amyloid burden in clinically normal elderly at risk for Alzheimer disease dementia. Assessments of the community-dwelling participants (aged 62 to 90 years) included medical history, physical exam, apolipoprotein E É4 genotyping, and Pittsburgh compound B (PiB) positron emission tomography (PET) amyloid imaging.

Dementia and Alzheimer Disease

 dementia and Alzheimer disease clinical focus page provides information, podcasts, videos, and news about the latest FDA actions, clinical guideline updates, study and clinical trial findings, and interviews with physicians related to the care of patients with dementia and similar diseases, including Lewy body dementia, frontotemporal dementia, Alzheimer disease, and more.

Why is a lower BMI linked to greater dementia risks in the elderly? Dr. Bobby Lazzara discusses a recent analysis using the Harvard Aging Brain Study.

BMI and Cortical Amyloid Burden in Elderly